FDA Authorizes Marketing of GI Genius
On April 9, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on…
Cancer
FDA Approves Abecma To Treat Multiple Myeloma
The U.S. Food and Drug Administration (FDA) approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not…
FDA Approves Cosela
On February 12, the U.S. Food and Drug Administration (FDA) approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of…
FDA: Black Salve is Dangerous and Called by Many Names
Recently FDA (Food and Drug Administration of U.S.) warns about Black Salve, that is actually can be dangerous for your health.On October 13, FDA published,…
FDA Approval For RET Cancer Drug Gavreto
Recently FDA Okayed Gavreto (pralsetinib) for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer. Gavreto approved under the FDA’s accelerated approval…
No Link Between Antihypertensive and Cancer Risk
According to the press release from ESC (European Society of Cardiology), there is no evidence that blood pressure lowering drugs (antihypertensive as an example) increase…
Oncology Drugs Cost And Pharmacy Operations
Pharmacologists can perform a role in the medical payment process for oncology outcomes (aside from other pharmacy operations), which are among the most important of…
The Chemotherapy Optimization: A Medication Trial
A medication trial for the therapy of chemotherapy-induced neutropenia (CIN) has confirmed specific issues.The PROTECTIVE (Study 106) advantage trial discovered that a marine-derived small-molecule (Plinabulin,…
The Blood Cancer: An Up-To-Date Research
Lymphoma is a variety of blood cancer related conditions, forming from lymphocytes (a type of white blood cell). It has multiple subtypes. A rare subtype,…
FDA Recommendation For Liver Cancer Treatment
On March 10, the Food and Drug Administration (FDA) recommended a union of the checkpoint inhibitors Opdivo (nivolumab) and Yervoy (ipilimumab) for people with exceptional…